| Patent | Date |
|---|
Pharmaceutical Compositions And Methods Targeting Wnt Pathway Proteins
App 20220023383 - Rabbani; Joshua ; et al. | 2022-01-27 |
Methods for treating bone loss using sclerostin peptides
Grant 11,167,011 - Rabbani , et al. November 9, 2 | 2021-11-09 |
Glucocerebroside Treatment Of Disease
App 20210260100 - Ilan; Yaron ; et al. | 2021-08-26 |
Sphingosine Kinase Type 1 Inhibitors And Uses Thereof
App 20210177776 - SPIEGEL; Sarah ; et al. | 2021-06-17 |
Sphingosine kinase type 1 inhibitors and uses thereof
Grant 10,945,971 - Spiegel , et al. March 16, 2 | 2021-03-16 |
Methods For Treating Psoriasis
App 20200331997 - ILAN; YARON ; et al. | 2020-10-22 |
Glucocerebroside Treatment Of Disease
App 20200281961 - ILAN; Yaron ; et al. | 2020-09-10 |
Methods for treating psoriasis
Grant 10,723,797 - Ilan , et al. | 2020-07-28 |
Sphingosine Kinase Type 1 Inhibitors And Uses Thereof
App 20200197328 - Spiegel; Sarah ; et al. | 2020-06-25 |
Glucocerebroside treatment of disease
Grant 10,639,324 - Ilan , et al. | 2020-05-05 |
Sphingosine kinase type 1 inhibitors and uses thereof
Grant 10,624,863 - Spiegel , et al. | 2020-04-21 |
Methods For Treating Psoriasis
App 20190352392 - Ilan; Yaron ; et al. | 2019-11-21 |
Sphingosine kinase type 1 inhibitors and uses thereof
Grant 10,456,370 - Spiegel , et al. Oc | 2019-10-29 |
Pharmaceutical Compositions And Methods Targeting Wnt Pathway Proteins
App 20190307842 - Rabbani; Joshua ; et al. | 2019-10-10 |
Pharmaceutical compositions targeting WNT pathway proteins
Grant 10,328,120 - Rabbani , et al. | 2019-06-25 |
Glucocerebroside Treatment Of Disease
App 20190060353 - Ilan; Yaron ; et al. | 2019-02-28 |
Sphingosine kinase type 1 inhibitors and uses thereof
Grant 10,166,204 - Spiegel , et al. J | 2019-01-01 |
Sphingosine kinase type 1 inhibitors and uses thereof
Grant 9,974,758 - Spiegel , et al. May 22, 2 | 2018-05-22 |
Glucocerebroside treatment of liver disorders
Grant 9,907,810 - Ilan , et al. March 6, 2 | 2018-03-06 |
Glucocerebroside Treatment Of Disease
App 20180042959 - ILAN; YARON ; et al. | 2018-02-15 |
Glucocerebroside Treatment Of Liver Disorders
App 20180042951 - ILAN; YARON ; et al. | 2018-02-15 |
Method For Treating Hiv
App 20180036326 - Ilan; Yaron ; et al. | 2018-02-08 |
Methods For Treating Melanoma
App 20180037648 - ILAN; Yaron ; et al. | 2018-02-08 |
Glucocerebroside treatment of liver disorders
Grant 9,744,185 - Ilan , et al. August 29, 2 | 2017-08-29 |
Glucocerebroside treatment of disease
Grant 9,717,754 - Ilan , et al. August 1, 2 | 2017-08-01 |
Method For Treating Hiv
App 20170042921 - ILAN; Yaron ; et al. | 2017-02-16 |
Methods for modulating Th1/Th2 cell balance by increasing leptin activity
Grant 9,421,257 - Ilan , et al. August 23, 2 | 2016-08-23 |
Sphingosine kinase type 1 inhibitors
Grant 9,388,121 - Spiegel , et al. July 12, 2 | 2016-07-12 |
Methods for decreasing leptin levels or activity for treating inflammation
Grant 8,969,291 - Ilan , et al. March 3, 2 | 2015-03-03 |
Biological function effecting viral vectors and chimeric cells useful as packaging cell lines and target cells
Grant 8,703,480 - Liu , et al. April 22, 2 | 2014-04-22 |
Antibodies against APRIL as biomarkers for early prognosis of lymphoma patients
Grant 8,609,821 - Huard , et al. December 17, 2 | 2013-12-17 |
Synthetic derivatives beta glycolipids and compositions thereof for the treatment of pathologic disorders
Grant 8,592,394 - Ilan , et al. November 26, 2 | 2013-11-26 |
Synthetic glycolipid analogues and derivatives for the treatment of pathologic disorders
Grant 8,586,564 - Ilan November 19, 2 | 2013-11-19 |
Sphingosine kinase type 1 inhibitors, compositions and processes for using same
Grant 8,372,888 - Zipkin , et al. February 12, 2 | 2013-02-12 |
Compositions and methods for bone formation and remodeling
Grant 8,367,822 - Wu , et al. February 5, 2 | 2013-02-05 |
Sphingosine kinase type 1 inhibitors, and processes for using same
Grant 8,314,151 - Spiegel , et al. November 20, 2 | 2012-11-20 |
Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom
Grant 8,012,456 - Brown , et al. September 6, 2 | 2011-09-06 |
Methods and uses of leptin in hepatocellular carcinoma
Grant 7,863,240 - Ilan , et al. January 4, 2 | 2011-01-04 |
Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences
Grant 7,816,130 - Liu , et al. October 19, 2 | 2010-10-19 |
Method for in vivo delivery of active compounds using reagent conjugate
Grant 7,713,528 - Rabbani , et al. May 11, 2 | 2010-05-11 |
Cell line for producing a non-retroviral vector
App 20090263895 - Liu; Dakai ; et al. | 2009-10-22 |
Retroviral vectors expressing exogenous gene or exogenous nucleic acid sequences
Grant 7,494,806 - Liu , et al. February 24, 2 | 2009-02-24 |
Independent helper virus packaging cell line for propagating viral vectors
Grant 7,439,060 - Liu , et al. October 21, 2 | 2008-10-21 |
Novel Property Effecting And/or Property Exhibiting Compositions For Therapeutic And Diagnostic Uses
App 20080248564 - Rabbani; Elazar ; et al. | 2008-10-09 |
Composition Of Matter Comprising Primary Nucleic Acid Component
App 20080108139 - Rabbani; Elazar ; et al. | 2008-05-08 |
Vectors for expressing exogenous gene or exogenous nucleic acid sequences
App 20070037284 - Liu; Dakai ; et al. | 2007-02-15 |
Viral vectors with surface or envelope components
App 20060183228 - Liu; Dakai ; et al. | 2006-08-17 |
Novel therapeutic processes for enhancing immunized states of vaccinated subjects
App 20050255454 - Ilan, Yaron ; et al. | 2005-11-17 |
Nucleic Acid displacer compositions and cells comprising same
App 20050053926 - Wetmur, James G. ; et al. | 2005-03-10 |
Regulation of immune responses by manipulation of intermediary metabolite levels
App 20040171526 - Ilan, Yaron ; et al. | 2004-09-02 |
Regulation of immune responses by manipulation of intermediary metabolite levels
App 20040171527 - Ilan, Yaron ; et al. | 2004-09-02 |
Regulation of immune responses by manipulation of intermediary metabolite levels
App 20040171528 - Ilan, Yaron ; et al. | 2004-09-02 |
Process useful for producing selective immune down regulation (SIDR) in subjects, including adult subjects to artificially expressed gene, gene delivery systems, infectious agents, and non-cellular immunogenic components, and processes for producing immunological tolerance in subjets using SIDR
App 20040022768 - Roy-Chowdhury, Jayanta ; et al. | 2004-02-05 |
Process for preventing or reducing undesirable immunological effects to infectious agents in subjects
App 20040023909 - Roy-Chowdhury, Jayanta ; et al. | 2004-02-05 |
Novel processes implementing selective immune down regulation (SIDR)
App 20030170258 - Roy-Chowdhury, Jayanta ; et al. | 2003-09-11 |
Branch migration of nucleotides
Grant 5,958,681 - Wetmur , et al. September 28, 1 | 1999-09-28 |
| 